Content about Tibotec

June 28, 2011
Gilead, Tibotec to develop HIV drug

A subsidiary of Johnson & Johnson and Gilead Sciences will collaborate to develop a combination drug for HIV, the two companies said Tuesday.

June 20, 2011
ReportersNotebook — Chain Pharmacy, 6/27/11

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

May 20, 2011
Edurant OKed as HIV treatment by FDA

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

February 14, 2011
Gilead resubmits HIV drug application to FDA

Gilead Sciences has refiled an approval application with the Food and Drug Administration for an HIV drug, the drug maker said.

January 27, 2011
Matrix obtains license agreement for HIV treatment

A Mylan subsidiary has inked a nonexclusive license agreement with Tibotec Pharmaceuticals to manufacture, market and distribute a generic version of an HIV treatment.

January 3, 2011
New strength of Intelence gets regulatory approval

The Food and Drug Administration has approved an update to the label of a Johnson & Johnson drug for HIV, the company said Monday.

December 14, 2010
FDA approves revised dosage of HIV-combo drug

The Food and Drug Administration has approved a revised dosage for a drug combination, which includes a Johnson & Johnson drug, in HIV patients who have received treatment but whose virus has not become immune to the J&J drug.

November 18, 2010
Report: J&J subsidiary, government officials seek to block HIV generic

Johnson & Johnson and the U.S. government are suing two generic drug makers to stop...

July 21, 2010
Tibotec unveils efficacy results for investigational HIV drug

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 1, 2010
Decision Resources projects peak sales for three HIV drugs

Three new drugs for treating HIV from Gilead Sciences and J&J subsidiary Tibotec could have...

January 27, 2010
FDA approves labeling update for HIV drug

Tibotec Therapeutics announced Thursday that the Food and Drug Administration has approved a labeling update...

© 2013 Drug Store News. All Rights Reserved.